Outbreaks of serious infectious diseases have tripled since 1980, increasing demands on the handful of labs in the US that research deadly pathogens.
The laboratory will be used for tuberculosis and multidrug resistant tuberculosis diagnosis and treatment. The lab will also be able to handle emerging infectious agents.
Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) is part of a national network of secure facilities that study emerging infectious diseases and develop diagnostic tests, treatments, and vaccines.
The Canadian Food Inspection Agency (CFIA) science head is leading a group of 11 high-risk labs from five developed countries in standardizing their protocols for preventing and responding to outbreaks, as well as transporting pathogens across borders.
The Level four laboratory has obtained authorization from the China National Accreditation Service for Conformity Assessment.
Infectious disease outbreaks have tripled globally since 1980 increasing demand on the few labs in the US that research deadly diseases.
Most of the biomedical facilities in Houston installed special doors and floodgates to hold back storm waters after Hurricane Allison.
There are several Biosafety Level 4 labs (BSL-4) at the Galveston National Laboratory.
This document reports on the status of the 13 AFRO Emerging and Dangerous Pathogen Laboratory Network (AFR EDPLN) laboratories.
The World Health Organization (WHO) Emerging and Dangerous Pathogen Laboratory Network (EDPLN) seeks to provide a diagnostic service for pathogenic agents in Africa.